Nidhogg Resources (NIDHOG) Q2 2025 earnings summary

Executive summary

• Completed reverse acquisition of Eurocine Vaccines, shifting focus to natural resources portfolio and resource extraction projects.

• No revenue generated in the quarter; strategic investments and planning for future income streams underway.

• Capital base restored through capital reduction and exercise of warrants, raising 5 MSEK.

• Geophysical surveys and acquisition of Vintjärn mine support transition to resource operations.

Financial highlights

• Revenue for the quarter was 0 TSEK, unchanged from the same period last year.

• Net loss after tax was -1,437 TSEK compared to -5 TSEK in the same quarter last year.

• Earnings per share for the period were -0.16 SEK, down from -0.0006 SEK year-over-year.

• Cash and cash equivalents at period end were 3,338 TSEK, up from 1,210 TSEK at June 30, 2024.

• Equity at period end was 3,638 TSEK, up from 909 TSEK at June 30, 2024.

Outlook and guidance

• Strategy to become income-generating in 2025 remains on track, with plans to process and sell material from mine waste heaps once permits are granted.

• Positive cash flow from trial mining at Tuna-Hästberg and Vintjärn-Kölen expected by late 2025.

• Ongoing evaluation of additional projects for portfolio expansion under strict investment criteria.